Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Question for the board: Deb I'll have some of what your having

May 31, 2007 07:38AM

May 31, 2007 07:54AM

Re: Question for the board: Deb I'll have some of what your having

in response to by
posted on May 31, 2007 08:01AM

RMBS is a manufaturer and therefore can legitimately establish damages based on lost sales whereas PTSC makes no product their ability to prove damages beyond licensing fees is difficult.

Too, Rmabus has recurring revenue nd R&D that serve to extend their cash flow series beyond a few years.

PTSC will have a market cap of 8 billion dollars at 20 dollas per share.  That seems a bit absurd when the  the portfolio was indepdndantly valued at only a few hundered million.

Even if PTSC can generate 1 billion in revenue over the next 3 years from licensing teh stock would not goto 20 without their ability to establish a sustainable perpetual earnings stream


May 31, 2007 08:15AM

May 31, 2007 08:21AM
Share
New Message
Please login to post a reply